Dr
Vincent
Jennings

Patent Director

Sheffield Office

Electronics

Telephone. +44(0) 114 274 3700
Email. [email protected]

Experience

Vincent has worked in private practice in Japan and the UK, and has broad experience drafting and prosecuting patent applications in the electrical and mechanical fields. Vincent has advised on subject matter including telecommunications, 2D and 3D printing technology, LCD displays, optical storage media and devices, memory arrays, semiconductor fabrication, computer software and document processing systems.

Although mainly representing large international corporations, Vincent also advises universities, SME's and individuals.

Vincent began his patent career in Osaka, Japan, where he gained experience of prosecuting US, European, Japanese and Chinese patent applications, and progressed to manage a team prosecuting electrical and mechanical patent applications. On returning to the UK, Vincent qualified as a UK and European patent attorney.

Vincent holds a master's degree in Mathematics and Physics from the University of Warwick and a PhD, also from the University of Warwick. His PhD research involved computer simulations of crystals, particularly ferroelectric perovskites. He presented the results of his research at various national and international conferences.

Qualifications

Patent Attorney

Chartered (UK)
European


MPHYS

MPhys (Maths and Physics)

PHD

PhD - Computational Simulations of Perovskites

Conferences: 2021

March 2nd 2021

Child Health Technology Conference 2021

Attended

Event details

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.